Home › NDC Lookup › RxCUI directory › RxCUI 2744506

12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / naproxen sodium 110 MG Ex... — RxCUI 2744506

RxNorm drug concept · Semantic clinical drug
RxCUI 2744506 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2744506
Official name12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / naproxen sodium 110 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan hydrobromide 30 MG / guaiFENesin 600 MG / naproxen sodium 110 MG 12HR Extended Release Oral Tablet
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Naproxen: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves pain, inflammation and fever. Prescription versions treat arthritis, tendonitis, bursitis, acute gout and painful periods. Over-the-counter versions handle minor aches...
  • Take it by mouth with a full glass of water. Over-the-counter products are taken every 8 to 12 hours while symptoms last, and you should use the smallest dose that works. For presc...
  • Headache, indigestion, heartburn, nausea and swelling are common. Call your doctor if you have black stools, vomit blood, a rash, yellow skin or eyes, or chest pain.
  • Usually not. Combining naproxen with other NSAIDs or aspirin raises bleeding risk with little added benefit. Naproxen can also interfere with low-dose aspirin taken for your heart,...
📖 Read our full Naproxen guide →

🕸️ Concept Web — How 12 HR dextromethorphan hydrobromide 30 MG / guai... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / naproxen sodium 110 MG Extended Release Oral Tablet RxCUI 2744506

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Dextromethorphan 3289
    • Guaifenesin 5032
    • Naproxen 7258
    • Dextromethorphan / guaifenesin / naproxen 2737699
    • Dextromethorphan hydrobromide 102490
    • Naproxen sodium 142442
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dextromethorphan / guaifenesin / naproxen Extended Release Oral Tablet 2744502
    • Dextromethorphan hydrobromide / guaifenesin / naproxen sodium Extended Release Oral Tablet 2744505
    • Dextromethorphan / guaifenesin / naproxen Oral Product 2744500
    • Dextromethorphan / guaifenesin / naproxen Pill 2744501
    • Dextromethorphan hydrobromide / guaifenesin / naproxen sodium Oral Product 2744503
    • Dextromethorphan hydrobromide / guaifenesin / naproxen sodium Pill 2744504
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dextromethorphan hydrobromide 30 MG 1045361
    • Guaifenesin 600 MG 316020
    • Naproxen sodium 110 MG 2744499

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dextromethorphan hydrobromide 30 MG SCDC · 1045361
  • Guaifenesin 600 MG SCDC · 316020
  • Naproxen sodium 110 MG SCDC · 2744499
  • Dextromethorphan / guaifenesin / naproxen Extended Release Oral Tablet SCDF · 2744502
  • Dextromethorphan hydrobromide / guaifenesin / naproxen sodium Extended Release Oral Tablet SCDFP · 2744505
  • Dextromethorphan / guaifenesin / naproxen Oral Product SCDG · 2744500
  • Dextromethorphan / guaifenesin / naproxen Pill SCDG · 2744501
  • Dextromethorphan hydrobromide / guaifenesin / naproxen sodium Oral Product SCDGP · 2744503
  • Dextromethorphan hydrobromide / guaifenesin / naproxen sodium Pill SCDGP · 2744504

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2744506 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72854-0001-16 2 BLISTER PACK in 1 CARTON (72854-001-16) / 8 TABLET, EXTEN... Mucinex 12HR Cold and Fever Multi-Symptom Reckitt Benckiser LLC 2026-06-01
72854-0001-32 4 BLISTER PACK in 1 CARTON (72854-001-32) / 8 TABLET, EXTEN... Mucinex 12HR Cold and Fever Multi-Symptom Reckitt Benckiser LLC 2026-06-01
72854-0001-50 5 BLISTER PACK in 1 CARTON (72854-001-50) / 10 TABLET, EXTE... Mucinex 12HR Cold and Fever Multi-Symptom Reckitt Benckiser LLC 2026-06-01
Observed labelers: Reckitt Benckiser LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.